Literature DB >> 10481856

Use of misoprostol in first and second trimester abortion: a review.

H C Scheepers1, E J van Erp, A S van den Bergh.   

Abstract

The use of misoprostol in medical termination of first and second term pregnancies and cervical priming in surgically induced termination of pregnancies has been studied extensively. A survey is given on the available literature (MEDLINE to May 1998) on the usage as a single medication or in combination with mifepristone or methotrexate. A review is given on literature concerning side effects and complications. Misoprostol is a most promising, cheap, and effective agent, which does not need cool storage like other prostaglandins. The use of misoprostol as an abortifacient has, however, not been supported by the manufacturer. This leads to the situation (similar to mifepristone/RU 486) that it is used and researched, but probably will not be officially approved for this specific indication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481856     DOI: 10.1097/00006254-199909000-00024

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  2 in total

1.  High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.

Authors:  Francis S Nuthalapaty; Patrick S Ramsey; Joseph R Biggio; John Owen
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Comparison of Vaginal and Oral Doses of Misoprostol for Labour Induction in Post-Term Pregnancies.

Authors:  Masomeh Rezaie; Fariba Farhadifar; Susan Mirza Mohammadi Sadegh; Morteza Nayebi
Journal:  J Clin Diagn Res       Date:  2016-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.